论文部分内容阅读
最近公布的一项研究结果显示,与单用辛伐他汀治疗相比,依泽替米贝/辛伐他汀联合治疗可以进一步降低LDL-C及CRP水平。
A recently published study shows that combination of ezetimibe / simvastatin can further reduce LDL-C and CRP levels compared with simvastatin alone.